Welcome to the latest edition of The Dose. This week, Kristen V. Brown from the health team fills in for Tiffany. She digs into the debate over how to bring psychedelic drugs to the masses.
Powerful substances face a vexing debate
The broad category of drugs we have come to call psychedelics are among the most buzzed-about in a very long time. Study results have been breathtaking, showing total symptom alleviation for conditions including post-traumatic stress disorder and depression in huge percentages of patients previously resistant to treatment. Equally astounding are the diverse conditions that these drugs might treat, from addiction and anorexia to migraines. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.